SCOPUS 정보 검색 플랫폼

Gynecologic Oncology

Volumn 85, Issue 2, 2002, Pages 278-284

Phase II evaluation of 3-day topotecan with cyclophosphamide in the treatment of recurrent ovarian cancer

(3) Hanjani, Parviz a Nolte, Susan a Shahin, Mark S a

a ABINGTON MEMORIAL HOSPITAL (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; TOPOTECAN;

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE CALCULATION; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; EVALUATION; FEBRILE NEUTROPENIA; FEMALE; HUMAN; NEUTROPENIA; OVARY CANCER; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RECURRENT CANCER; SURVIVAL TIME; THROMBOCYTOPENIA;

EID: 0036097633 PISSN: 00908258 EISSN: None Source Type: Journal
DOI: 10.1006/gyno.2002.6593 Document Type: Article

Times cited : (13)

References (34)

1
- 0035114558
- Cancer statistics 2001
- (2001) CA Cancer J Clin , vol.51 , Issue.1 , pp. 15-38
- Greenlee, R.T.¹ Hill-Harmon, M.B.² Murray, T.³ Thun, M.⁴

2
- 0030054309
- Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer
- (1996) N Engl J Med , vol.334 , Issue.1 , pp. 1-6
- McGuire, W.P.¹ Hoskins, W.J.² Brady, M.F.³ Kucera, P.R.⁴ Partridge, E.E.⁵ Look, K.Y.⁶ Clarke-Pearson, D.L.⁷ Davidson, M.⁸

3
- 0006080701
- Trends in five-year survival rates by race and year of diagnosis, 1974-1996
- (2001) Cancer Facts Fig , pp. 18-19

4
- 0027972726
- Topoisomerase I inhibitors: Topotecan and irinotecan
- (1994) Cancer Treat Rev , vol.20 , pp. 73
- Creemers, G.J.¹ Lund, B.² Verweij, J.³

5
- 0000626027
- A phase II trial of topotecan as a salvage therapy in epithelial ovarian cancer
- (1995) Proc Am Soc Clin Oncol , vol.14
- Armstrong, D.¹ Rowinsky, E.² Donchower, R.³ Rosenshein, N.⁴ Walczak, J.⁵ McGuire, W.⁶

6
- 0031786482
- Topotecan for the treatment of advanced epithelial ovarian cancer: An open-label phase II study in patients treated after prior chemotherapy that contained cisplatin or carboplatin and paclitaxel
- (1998) J Clin Oncol , vol.16 , Issue.10 , pp. 3345-3352
- Bookman, M.A.¹ Malmstrom, H.² Bolis, G.³ Gordon, A.⁴ Lissoni, A.⁵ Krebs, J.B.⁶ Fields, S.Z.⁷

7
- 9244247616
- Phase II study of intravenous topotecan as a 5-day infusion for refractory ovarian carcinoma
- (1996) J Clin Oncol , vol.145 , pp. 1552-1557
- Kudelka, A.¹ Tgreskusol, D.² Edwards, C.L.³ Freedman, R.S.⁴ Levenback, C.⁵ Chantarawiroj, P.⁶ Gonzalez de Leon, C.⁷ Kim, E.E.⁸ Madden, T.⁹ Wallin, B.¹⁰ Hord, M.¹¹ Verschraegen, C.¹² Raber, M.¹³ Kavanagh, J.J.¹⁴

8
- 0026537874
- Phase I and pharmacologic study of topotecan: A novel topoisomerase I inhibitor
- (1992) J Clin Oncol , vol.10 , pp. 647-656
- Rowinsky, E.K.¹ Grochow, L.B.² Hendricks, C.B.³

9
- 0027323646
- Phase I clinical and pharmacology study of topotecan given daily for 5 consecutive days to patients with advanced solid tumors, with attempt at dose intensification using recombinant granulocyte colony-stimulating factor
- (1993) J Natl Cancer Inst , vol.85 , Issue.18 , pp. 1499-1507
- Saltz, L.¹ Sirott, M.² Young, C.³ Tong, W.⁴ Niedzwiecki, D.⁵ Tzy-Jyun, Y.⁶ Tao, Y.⁷ Trochanowski, B.⁸ Wright, P.⁹ Barbosa, K.¹⁰

10
- 0033770154
- Phase 2 evaluation of topotecan administered on a 3-day schedule in the treatment of platinum and paclitaxel-refractory ovarian cancer
- (2000) Gynecol Oncol , vol.79 , pp. 116-119
- Markman, M.¹ Kennedy, A.² Webster, K.³ Kulp, B.⁴ Peterson, G.⁵ Belinson, J.⁶

11
- 0000286226
- Treatment of human cancer xenografts with camptothecin analog in combination with cytoxan or irradiation
- (1994) Proc Am Assoc Cancer Res , vol.35 , pp. 454
- Giovanella, B.¹ Potmesil, M.² Wall, M.E.³

12
- 0031595047
- Synergistic cytotoxicity of topoisomerase I inhibitors with alkylating agents and etoposide in human brain cell lines
- (1998) Anti Cancer Drugs , vol.9 , pp. 641-652
- Janss, A.J.¹ Cnaan, A.² Zhao, H.³ Shpilsky, A.⁴ Levow, C.⁵ Sutton, L.⁶ Phillips, P.C.⁷

13
- 0035424844
- Cyclophosphamide plus topotecan in children with recurrent or refractory solid tumors: A pediatric oncology group phase II study
- (2001) J Clin Oncol , vol.19 , Issue.15 , pp. 3463-3469
- Saylors, R.L.¹ Stine, K.C.² Sullivan, J.³ Kepneer, J.L.⁴ Wall, D.A.⁵ Bernstein, M.L.⁶ Harris, M.B.⁷ Hayashi, R.⁸ Vietti, T.J.⁹

14
- 0034517204
- Topotecan (hycamtin) and topotecan-containing regimens in the treatment of hematologic malignancies
- (2000) Ann NY Acad Sci , vol.922 , pp. 247-259
- Beran, M.¹ Kantarjian, H.M.²

15
- 17144447367
- Dose escalation and phamacodynamic study of topotecan in combination with cyclophosphamide in patients with refractory cancer
- (1997) J Clin Oncol , vol.15 , pp. 148-157
- Murren, J.R.¹ Anderson, S.² Fedele, J.³ Pizzorno, G.⁴ Bellivedu, D.⁵ Zelterman, D.⁶ Burtness, B.A.⁷ Tocino, I.⁸ Flynn, S.D.⁹ Beidler, D.¹⁰ Cheng, Y.C.¹¹

16
- 0024536437
- Optimal two-stage designs for phase II clinical trials
- (1989) Control Clin Trials , vol.10 , pp. 1-10
- Simon, R.¹

17
- 0029067168
- Carboplatin reinduction after taxane in patients with platinum refractory-epithelial ovarian cancer
- (1995) J Clin Oncol , vol.13 , Issue.7 , pp. 1584-1588
- Kavanagh, J.¹ Tresukosol, D.² Edwards, C.³ Freedman, R.⁴ Gonzalez de Leon, C.⁵ Fishman, A.⁶ Mante, R.⁷ Hord, M.⁸ Kudelka, A.⁹

18
- 0030000142
- Paclitaxel retreatment in patients with platinum and paclitaxel resistant ovarian cancer
- (1996) Eur J Gynecol , vol.17 , Issue.3 , pp. 188-191
- Tresukosol, D.¹ Kuldeka, A.P.² Gonzalex de Leon, C.³ Edwards, C.L.⁴ Freedman, R.S.⁵ Mante, R.⁶ Hord, M.⁷ Kavanagh, J.J.⁸

19
- 0031036177
- Phase I and pharmacologic study of paclitaxel administered weekly in patients with relapsed ovarian cancer
- (1997) J Clin Oncol , vol.15 , Issue.1 , pp. 187-192
- Fennelly, D.¹ Aghajanian, C.² Shapiro, F.³ O'Flaherty, C.⁴ McKenzie, M.⁵ O'Connor, C.⁶ Tong, W.⁷ Norton, L.⁸ Spriggs, D.⁹

20
- 0031894188
- Prolonged oral etoposide as second-line therapy for platinum-resistant and platinum-sensitive ovarian carcinoma: A Gynecologic Oncology Group study
- (1998) J Clin Oncol , vol.16 , Issue.2 , pp. 405-410
- Rose, P.G.¹ Blessing, J.A.² Mayer, A.R.³ Homesley, H.D.⁴

21
- 0031055830
- Phase II study of liposomal doxorubicin in refractory ovarian cancer: Antitumor activity and toxicity modification by liposomal encapsulation
- (1997) J Clin Oncol , vol.15 , Issue.3 , pp. 987-993
- Muggia, F.M.¹ Hainesworth, J.D.² Jeffers, S.³ Miller, P.⁴ Groshen, S.⁵ Tan, M.⁶ Roman, L.⁷ Uziely, B.⁸ Muderspach, L.⁹ Garcia, A.¹⁰ Burnett, A.¹¹ Greco, F.A.¹² Morrow, C.P.¹³ Paradiso, L.J.¹⁴ Liang, L.J.¹⁵

22
- 0030014334
- Phase II study of docetaxel in patients with epithelial ovarian carcinoma refractory to platinum
- (1996) Clin Cancer Res , vol.2 , Issue.5 , pp. 837-842
- Kavanagh, J.J.¹ Kudelka, A.P.² De Leon, C.G.³ Tresukosol, D.⁴ Hord, M.⁵ Finnegan, M.B.⁶ Kim, E.E.⁷ Varma, D.⁸ Forman, A.⁹ Cohen, P.¹⁰ Edwards, C.L.¹¹ Freedman, R.S.¹² Verschraegen, C.F.¹³

23
- 0030201090
- Tamoxifen in platinum-refractory ovarian cancer: A Gynecologic Oncology Group ancillary report
- (1996) Gynecol Oncol , vol.62 , pp. 4-6
- Markman, M.¹ Iseminger, K.A.² Hatch, K.D.³

24
- 0030272511
- Activity of gemcitabine in patients with advanced ovarian cancer: Responses seen following platinum
- (1996) Gynecol Oncol , vol.63 , Issue.1 , pp. 89-93
- Shapiro, J.D.¹ Millaward, M.J.² Rischin, D.³ Michael, M.⁴ Walcher, V.⁵ Francis, P.A.⁶ Toner, G.C.⁷

25
- 0032103330
- Altretamine (hexamethylmelamine) in platinum-resistant and platinum-refractory ovarian cancer: A gynecologic oncology group phase II trial
- (1998) Gynecol Oncol , vol.69 , pp. 226-230
- Markman, M.¹ Blessing, J.A.² Moore, D.³ Ball, H.⁴ Lentz, S.S.⁵

26
- 0001951950
- Combination regimens with topotecan in animal tumor models
- (1992) Ann Oncol , vol.3 , pp. 85-88
- Johnson, R.K.¹ McCabe, F.L.² Yu, Y.³

27
- 0031905299
- In vitro and in vivo interaction between cisplatin and topotecan in ovarian carcinoma systems
- (1998) Cancer Chemother Pharmacol , vol.41 , Issue.5 , pp. 385-390
- Romanelli, S.¹ Perego, P.² Pratesi, G.³ Carenini, N.⁴ Tortoreto, M.⁵ Zunino, F.⁶

28
- 0000623584
- Synergestic cytotoxicity with combined inhibition of topoisomerase topo I and II
- (1992) Proc Am Soc Clin Oncol , vol.11 , pp. 431
- Anzai, H.¹ Frost, P.² Abbrruzzese, J.L.³

29
- 0031793524
- Synergestic interactions of combinations of topotecan with standard drugs in primary cultures of human tumor cells from patients
- (1998) Eur J Clin Pharmacol , vol.54 , pp. 509-514
- Jonsson, E.¹ Fridborg, H.² Nygren, P.³ Larson, R.⁴

30
- 0032708102
- Role of salvage chemotherapy with topotecan and cisplatin in patients with paclitaxel and platinum-resistant recurrent ovarian or primary peritoneal cancer: A phase II pilot study
- (1999) J Surg Oncol , vol.72 , pp. 162-166
- Ghamande, S.A.¹ Piver, M.S.²

31
- 0034445444
- A phase I study of liposomal doxorubicin (Doxil) with topotecan
- (2000) Am J Clin Oncol , vol.23 , Issue.3 , pp. 297-300
- Ryan, C.W.¹ Fleming, G.F.² Janisch, L.³ Ratain, M.J.⁴

32
- 0035165048
- Topotecan and gemcitabine in platinum/paclitaxel-resistant ovarian cancer
- (2001) Oncology , vol.60 , pp. 19-23
- Greggi, S.¹ Salerno, M.G.² D'Agostino, G.³ Ferrandina, G.⁴ Lorusso, D.⁵ Manzione, L.⁶ Mancuso, S.⁷ Scambia, G.⁸

33
- 1542667103
- Topotecan (T) and cyclohosphamiude (Cy) in second line treatment of advanced ovarian cancer: A GINECO phase II trial
- (2001) Proc Am Soc Clin Oncol , vol.20
- Vannetzel, J.¹ Fabbro, M.² Weber, B.³ Mayeer, F.⁴ Peaud, J.⁵ Tigaud, J.⁶ Ferrero, J.⁷ Orfeuve, H.⁸ Bouffette, P.⁹ Ganem, G.¹⁰ Kaminsky, M.¹¹ Paraiso, D.¹² Pujade-Lauraine, E.¹³

34
- 0026620239
- The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: A Gynecologic Oncology Group study
- (1992) Gynecol Oncol , vol.47 , pp. 159-166
- Hoskins, W.J.¹ Bundy, B.N.² Thigpen, J.T.³ Omura, G.A.⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.